Maven posted on I flub: FITX investor community, I have

New Post Public Reply Private Reply Replies (5) Message Board
Cowmos
Maven posted on I flub: FITX investor community,

I have only been able to sporadically follow today's dialogue on this board concerning the article released today in the Windsor Star and the content within that is apparently shaking investor confidence in FITX and its current construction project in Lakeshore. I have read the article, and I have some problems with it. I intend to address 1) a statement on the part of the reporter, Monica Wolfson, and 2) a specific statement attributed to a Mr. Steve Salmons, who is listed as the Director of Community and Development Services. My intention is to point out an error on the part of Ms. Wolfson's facts, and a seemingly significant inconsistency on the part of Mr. Salmons and his issue with FITX. For the record, as I previously stated, I have only been able to follow today's ihub dialogue sporadically, so if anything I cover in this post is old news, I sincerely apologize for wasting the reader's time. It is merely my desire to contribute in a positive manner to the dialogue for the benefit of all concerned.

Ms. Wolfson's article states that, "[a]t issue is the construction and zoning of a 53,000-square foot pole barn." Then the article goes on to state that:

[begin quote]
"It's the town's contention that the barn cannot be outfitted with electricity, water, sewer, a vault or even bathrooms under the property's current agriculture value added zoning. A barn is supposed to be for storage of farming equipment or farming product.

The 'value added' designation allows some flexibility for processing of agriculture product, except it's limited to a 6,000-square foot facility and no more than five employees, Salmons told council Tuesday.

Salmons said he sent the letter to CEN Biotech because the company was putting out press releases and reporting through media stories and in YouTube videos information that contradicted what company officials told the town in meetings before Christmas.

'There seems to be a lot going on that's inconsistent with a 6,000-square-foot facility,' Salmons said. [end quote]

While I know that a link to this article has been posted on this board many times today, for the ease of the reader, and particularly newcomers to the dialogue, all may view the article here:

http://blogs.windsorstar.com/2014/04/08/lakes...operation/

Now then, my first issue is with Ms. Wolfson's statement that "...the company was putting out press releases... that contradicted what company officials told the town in meetings before Christmas."

At present, I will freely admit that I have no direct evidence to argue against Ms. Wolfson's statement, because I have not researched what CEN Biotech has told the town. However I will show that the town council has known about CEN Biotech's intentions at least since November of 2013. Please bear with me...

My second issue is with Mr. Salmons' statement that " here seems to be a lot going on that's inconsistent with a 6,000-square-foot facility".

Admittedly, Mr. Salmons IS correct. There ARE a lot of things going on onsite that are VERY inconsistent with a 6,000-square-foot facility. One has only to look at the photos made available by Mr. Chaaban, the CEO of CEN Biotech, and by various investor-friends and interested parties in Lakeshore who have graciously taken their time to post pictures of the build site (my thanks to them). The construction looks wonderful, the building will be HUGE, and progress is occurring at pace. It is painfully, nay, blatantly obvious that this will be no simple "6,000-square-foot facility".

HOWEVER, I have to question either the motives, or the professionalism of Ms. Wolfson, and the motives of Mr. Salmons, on the grounds of information that is readily available online from the Lakeshore Council Minutes, dated November 12, 2013. Specifically, beginning on page 31, in a statement addressed to "Mayor and Members of Council" from "Steve Salmons, Director".

In the statement, the first section, headed as "Background", briefly describes the Canadian Government's 2012 decision to change its laws regarding medical marijuana (or marihuana, for the sake of our Canadian brothers and sisters). The "Background" finishes with this statement:

"Lakeshore has been notified by CEN Biotech Inc that it has applied to [H]ealth Canada for a license in Lakeshore (as required by the new regulations)"

The next section in these minutes, entitled "Comments", gets straight to the point:

[begin quote]
"The proposed location is at Manning and North Rear Road (south of the OPP detachment at [M]anning and 401). It has the correct zoning.

The site is zoned "Agricultural Use- Value Added" that provides an accessory use for processing and refining agricultural product to a final retail product. The final retail product shall primarily consist of inputs produced on the farm.

The proponent has applied to construct a 58,000 s.q. steel barn to grow and process the plants. There is also a fencing application to secure the facility. In a meeting with the proponents, they explained that there would be a number of sophisticated security measures in addition to air filtration to remove vapors and odors.

The application is currently in progress." [end quote]

For the benefit of fellow investors and interested parties, please do not take my word for it. You can find the minutes here:

http://weblink8.lakeshore.ca/WebLink8/DocView...amp;dbid=1

Or, if this link doesn't work for you, then try this link to the Town of Lakeshore - Agendas,...

http://www.townoflakeshore.on.ca/lakeshore_1?page=62#minutes

and then click on "Council Minutes", then select the folder for 2013 Agendas, then select the folder for "November 12, 2013 - Regular Council Meeting", then go to page 31.

Or, if all of that doesn't work, go to this link:

http://www.townoflakeshore.on.ca/

and click on the "Search Bylaws & Council Agendas/Meeting" button on the quick links menu in the middle of the page, and proceed accordingly.

The point is that CEN Biotech made efforts to be both transparent AND forthcoming about their intentions in Lakeshore, as is obvious in the Council's record of minutes from November 12, 2013. Incorrect spacial facts aside ("53,000 s.f.," as opposed to the official "58,000 s.f" dimensions of the facility), for Ms. Wolfson to say that Mr. Chaaban and co. have been issuing press releases in a myriad of media outlets that are "contrary" to what they told the town, is really just trash talking. It may, in fact, not be false, because, again, I don't know what Mr. Chaaban and co. have said to THE TOWN. However, the town's LEADERSHIP has been FULLY aware of CEN's intentions regarding the size, location, and purpose of the facility under construction, for almost five months, as per their own Council's recorded minutes.

Furthermore, Mr. Salmon's statement from the Windsor Star article, as quoted previously, is actually directly contrary to the information that he, himself, supplied to the "Mayor and Council Members" regarding the size and purpose of CEN's facility, as per his own statement listed in the noted Council Minutes.

In conclusion, I have never met or had any communication with Mr. Chaaban, and therefore cannot speak to the quality of his character, nor of his true intentions regarding the facility under construction. AND as a shareholder in FITX, and being aware of the company's history, I am certainly concerned for FITX's success, and wary of the risks involved. Nonetheless... something funky is going on up in Lakeshore, and if Mr. Chaaban's statements or behavior are in the least bit questionable, then I would suggest that that goes double for a local reporter, and triple for a back-stabbing Director of Community and Development Services. Thus, I am more than willing to give Mr. Chaaban some breathing room to get on with the business of building the business. So far, regarding the facility, he has done what he has said he was going to do, and he has obviously taken the appropriate steps to make sure that the town officials, and by extension, the town, understand what CEN Biotech is doing in Lakeshore. I find it deplorable that a local reporter can't get facts straight, and that a local official is speaking out of two sides of his mouth and endangering what has amounted to months of work on the part of many,and millions of dollars spent, in pursuit of a perfectly legal and legitimate enterprise. The Lakeshore community and FITX's investor community all have so much to gain from the completion of this project, and Mr. Chaaban has evidently been working diligently to make it happen. The project is not too big to fail, but I would argue that, with so much at stake, particularly for Lakeshore, the project is too big to LET fail. God or the Fates, please save us from irresponsible reporters and fork-tongued officials.

Creative Edge Nutrition Inc. (FITX) Stock Research Links

FITX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Drone Composites Market Set for Major Growth by 2031

Updated Category News Views 108

Drone Composites: A Market Poised for Surge Strap in, folks! The drone composites market is gearing up for a wild ride, projected to nearly double from $7.06 billion in 2026 to a whopping $13.59 billion by 2031. That's a solid 14% compound annual growth rate (CAGR) for those keeping score at home. With those numbers, it's no wonder market players are strategizing hard to...

Continue Reading
ATRenew Gears Up: Q3 Financial Results Insight

Updated Category News Views 61

Anticipation Builds for ATRenew's Q3 Release Alright folks, mark your calendars and get that caffeine ready—November 19th is about to be interesting for those tracking NYSE: RERE. ATRenew, the tech-driven recycling pioneer, will drop its latest financial crumbs before the U.S. market wakes up. Another earnings call to dissect, and hopefully, one that doesn't bore us to...

Continue Reading
NORROY's Radiopharma Innovations: EANM Highlights

Updated Category News Views 68

Breaking Ground: NORROY's Radiopharmaceutical Innovations If you thought the radiopharmaceutical game was stuck in the same ol' rut, NORROY Bioscience just flipped the script. Standing out at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM'26) in Vienna, they trotted out enough breakthroughs to make you wonder if they're secretly running on...

Continue Reading
GradBridge Unveils HQ to Bolster Fintech Growth

Updated Category News Views 52

Milestone Moment for GradBridge's Expansion Picture this: a fintech upstart in Delaware, making waves with its innovative approach to student lending. That's exactly what's happening with GradBridge as they open their new headquarters at Newark's Iron Hill Corporate Center. This isn't just about cutting a ribbon; it's a declaration that they're serious about shaking...

Continue Reading
Webull Legal Woes: Investors Eye Class Action Lead Role

Updated Category News Views 114

Legal Firestorm for Webull Sparks Investor Action Amidst the noise of digital investment platforms, Webull Corporation, ticker NASDAQ:BULL, finds itself not just trading stocks but facing a potential legal landmine. The clock's ticking for investors who've seen substantial losses to step up as lead plaintiff in a looming class action lawsuit. This isn’t some sideshow;...

Continue Reading
RetailMeNot Boosts Holiday Budget with Cash Back Extravaganza

Updated Category News Views 25

This Isn't Your Grandma's Cash Back Here we go, folks! RetailMeNot is rolling out the red carpet for budget-conscious gift givers with its National Cash Back Day. From November 5–7, over 3,500 retailers, including big shots like Walmart and Ulta, are letting you scoop up to 30% in cold, hard cash back. If you ever needed a reason to start your holiday shopping early,...

Continue Reading
AlphaESS Secures Fifth Tier 1 Status Amid Growth

Updated Category News Views 136

AlphaESS: Consistency Breeds Success Can't ignore a company that keeps hitting the marks quarter after quarter, kid. AlphaESS just bagged its fifth consecutive Tier 1 status from BloombergNEF for Q4 2026—that's no joke in the buzzing world of energy storage. What makes this outfit tick? It's not just sticking to the same old script; they keep leveling up while everyone...

Continue Reading
Union Pacific-Norfolk Southern Merger: A Game Changer?

Updated Category News Views 169

What's the Big Deal with This Merger? Take a hard look at the Union Pacific-Norfolk Southern merger, and you start to see numbers that could make any grizzled investor sit up and pay attention. This isn't just a boardroom shuffle—it’s about potentially giant leaps in economic and health benefits. William Michael Cunningham pulls no punches in his latest study. He puts...

Continue Reading
FFR Bolsters Robotics Edge with Key Academic Partnerships

Updated Category News Views 124

Let’s talk about what’s cooking in the robotics world, where FF EAI Robotics Ecosystem (NASDAQ: FFR), a heavyweight in the AI robotics ring, is shaking hands with academic giants to fast-track innovation. On November 4, 2026, FFR revealed a strategic alliance with two academic powerhouses—the California Science and Technology University (CSTU) and the Boston...

Continue Reading
American Bitcoin Sees 5% Hike in Satoshis Per Share

Updated Category News Views 60

Digging Deeper into American Bitcoin's Latest Results Out of the blue, American Bitcoin Corp. (NASDAQ:ABTC) has dropped its third-quarter 2026 financial results, and guess what? It's looking like they've struck gold—or should I say, digital gold. The Miami-based operation is all about stacking those Bitcoins, weaving them into their business model like a knitter with a...

Continue Reading

Top 5 Most Recently Viewed Articles

Amniotic Membrane Market Shows Promising Growth Potential

Updated Category News Views 116

Emerging Trends in the Amniotic Membrane Market The amniotic membrane market is on a remarkable growth trajectory due to the increasing application of amniotic membrane products across various medical sectors. This includes areas such as ophthalmology, dermatology, and surgical wound management. The growth of this market can be attributed to the rising demand for...

Continue Reading
Strategic Merger: Katapult, Aaron’s, and CCF Holdings Unite

Updated Category News Views 106

Major Merger Announcement: Katapult, Aaron's, and CCF Holdings Katapult Holdings, Inc. (NASDAQ: KPLT) has announced an exciting new chapter in its history by entering into a definitive agreement to merge with The Aaron’s Company, Inc. and CCF Holdings LLC. This all-stock transaction aims to establish a robust omni-channel platform designed specifically for non-prime...

Continue Reading
USIO Faces Challenges as Stock Hits 52-Week Low of $1.3

Updated Category News Views 110

USIO Experiences a Significant Decline Recently, shares of Payment Data Systems Inc (USIO) have unfortunately reached a 52-week low at $1.3, amid a challenging financial landscape. This marks a substantial drop of -34.08% over the past year, leaving investors uncertain about the company's future. Known for its integrated payment solutions, USIO has been facing hurdles...

Continue Reading
Northwest Bank Adjusts Prime Rate to 7.00 Percent for Clients

Updated Category News Views 202

Northwest Bank Reduces Prime Lending Rate In a significant update for its customers, Northwest Bank has lowered its prime lending rate to 7.00 percent, down from 7.25 percent. This change is effective immediately and aims to provide better financial options to both personal and business banking customers. Overview of Rate Changes The previous change in Northwest's prime...

Continue Reading
Albemarle Corporation Announces Q3 2024 Earnings Release

Updated Category News Views 111

Albemarle Corporation (NYSE: ALB) had its third-quarter 2024 earnings release on deck back in October 2024. This kind of news always stirs the pot, especially when it comes to how the numbers will shake out given Albemarle's heavy presence in lithium production—a hot commodity with electric vehicle markets surging. What’s at Stake for Albemarle? Earnings Dynamics...

Continue Reading